Patents Assigned to University
-
Patent number: 9554563Abstract: A mouse with a humanization of the mIL-3 gene and the mGM-CSF gene, a knockout of a mRAG gene, and a knockout of a mIl2rg subunit gene; and optionally a humanization of the TPO gene is described. A RAG/Il2rg KO/hTPO knock-in mouse is described. A mouse engrafted with human hematopoietic stem cells (HSCs) that maintains a human immune cell (HIC) population derived from the HSCs and that is infectable by a human pathogen, e.g., S. typhi or M. tuberculosis is described. A mouse that models a human pathogen infection that is poorly modeled in mice is described, e.g., a mouse that models a human mycobacterial infection, wherein the mouse develops one or more granulomas comprising human immune cells. A mouse that comprises a human hematopoietic malignancy that originates from an early human hematopoietic cells is described, e.g., a myeloid leukemia or a myeloproliferative neoplasia.Type: GrantFiled: October 14, 2013Date of Patent: January 31, 2017Assignees: Regeneron Pharmaceuticals, Inc., Yale University, Institute for Research in Biomedicine (IRB)Inventors: Sean Stevens, Andrew J. Murphy, Richard Flavell, Elizabeth Eynon, Jorge Galan, Tim Willinger, Markus Manz, Anthony Rongvaux, George D. Yancopoulos
-
Patent number: 9555011Abstract: The present invention includes compositions and methods of making an activated polymeric nanoparticle for targeted drug delivery that includes a biocompatible polymer and an amphiphilic stabilizing agent non-covalently associated with a spacer compound that includes at least one electrophile that selectively reacts with any nucleophilic on a targeting agent and places the targeting agent on the exterior surface of a biodegradable nanoshell, wherein an active agent is loaded with the nanoshell.Type: GrantFiled: April 7, 2015Date of Patent: January 31, 2017Assignee: University of North Texas Health Science Center at Fort WorthInventors: Arthur R. C. Braden, Jamboor K. Vishwanatha
-
Patent number: 9555020Abstract: Methods of treatment in subjects suffering from diabetes mellitus or obesity are provided. The methods comprise the step of administering an active agent directly to the small intestine in the subject. In particular, the active agent may be administered directly to the duodenum in the subject. The active agents useful in the treatments described herein include analgesic agents and, in particular, antinociceptive agents such as capsaicin, resiniferatoxin, and their analogs.Type: GrantFiled: July 18, 2012Date of Patent: January 31, 2017Assignee: The Board of Trustees of the Leland Stanford Junior UniversityInventors: Pankaj Jay Pasricha, Liansheng Liu
-
Patent number: 9556170Abstract: The present invention provides compounds which are useful as inhibitors of lysine-specific demethylase 1 (“LSD1”). The present invention also relates to pharmaceutical compositions containing these compounds. The present invention also relates to a method for preparing these compounds. The present invention also relates to a method of treating a mammalian disorder in which LSD1 levels are elevated by administering these compounds and compositions to a patient in need thereof. The present invention also relates to a method for decreasing histone demethylase activity in a mammal comprising administering to the mammal an effective amount of these compounds and compositions.Type: GrantFiled: August 28, 2014Date of Patent: January 31, 2017Assignee: University of Utah Research FoundationInventors: Hariprasad Vankayalapati, Sunil Sharma, Venkataswamy Sorna
-
Patent number: 9556458Abstract: The present invention relates to methods and compositions for increasing production of methyl ketones in a genetically modified host cell that overproduces ?-ketoacyl-CoAs through a re-engineered ?-oxidation pathway and overexpresses FadM.Type: GrantFiled: October 26, 2012Date of Patent: January 31, 2017Assignee: The Regents of the University of CaliforniaInventors: Harry R. Beller, Ee-Been Goh
-
Patent number: 9560464Abstract: The system and method of the present invention rely on combining the Speakers+Room binaural Impulse Response(s) (SRbIR) with a special kind of crosstalk cancellation (XTC) filter—one that does not degrade or significantly alter the SRbIR's spectral and temporal characteristics that are required for effective head externalization. This unique combination leads to a 3D audio filter for headphones that allows the emulation of the sound of crosstalk-cancelled speakers through headphones, and allows for fixing the perceived soundstage in space using head tracking and thus solves the major problems for externalized and robust 3D audio rendering through headphones. Furthermore, by taking advantage of a well-documented psychoacoustic fact, this system and method can produce universal 3D audio filters that work for all listeners i.e. independent of the listener's head related transfer function (HRTF).Type: GrantFiled: November 25, 2014Date of Patent: January 31, 2017Assignee: The Trustees of Princeton UniversityInventor: Edgar Y. Choueiri
-
Patent number: 9556217Abstract: Bringing membrane proteins into aqueous solution generally requires the use of detergents or other amphiphilic agents. The invention provides a new class of amphiphiles, each of which includes a multi-fused ring system as a lipophilic group. These new amphiphiles confer enhanced stability to a range of membrane proteins in solution relative to conventional detergents, leading to improved structural and functional stability of membrane proteins, including integral membrane proteins. Accordingly, the invention provides new amphiphiles for biochemical manipulations and characterization of membrane proteins. These amphiphiles display favorable behavior with membrane proteins and can be used to aid the solubilization, isolation, purification, stabilization, crystallization, and/or structural determination of membrane proteins.Type: GrantFiled: November 3, 2015Date of Patent: January 31, 2017Assignees: Wisconsin Alumni Research Foundation, The Board of Trustees of the Leland Stanford Junior UniversityInventors: Samuel Helmer Gellman, Pil Seok Chae, Brian Kobilka, Soren Rasmussen
-
Patent number: 9559422Abstract: The disclosure provides a communication device. The communication device includes a ground conductor portion and a multi-antenna system. The multi-antenna system includes at least a first and a second resonant portion, each of which is disposed on the corresponding radiating edge of the ground conductor portion. Each of the resonant portions may have a loop resonant structure or may have an open-slot resonant structure, and has a resonant path. The electrically coupling portion makes the length of the resonant path less than or equal to 0.18 times the wavelength of the lowest operating frequency of the multi-antenna system, and thereby excites the corresponding radiating edge and forms a strong surface current distribution, and generates an effective radiating energy and at least one resonant mode, in which the effective radiating energy has a corresponding strongest radiation direction.Type: GrantFiled: August 15, 2014Date of Patent: January 31, 2017Assignees: Industrial Technology Research Institute, National Sun Yat-sen UniversityInventors: Kin-Lu Wong, Yeh-Chun Kao, Po-Wei Lin, Wei-Yu Li
-
Patent number: 9558616Abstract: The gaming machine includes: a cabinet having a display window; one or more reels disposed in the cabinet so that the or each reel is visible from outside the cabinet through the display window, the or each of the one or more reels being provided with a reel band having symbols; and a light application device configured to apply visible light representing visual information which enables recognition of information related to games to the reel band. The or each of one or more reels has a mirror layer which reflects the visible light from the light application device. The light application device is disposed in an area outside the window frame of the display window so that the visible light is applied to the reel, on the side of the reel band.Type: GrantFiled: April 25, 2013Date of Patent: January 31, 2017Assignees: Universal Entertainment Corporation, Aruze Gaming America, Inc.Inventors: Yoshinori Kondo, Jun Hirato, Kenta Kitamura, Takehisa Itagaki
-
Patent number: 9556432Abstract: This disclosure provides a novel role for microRNA (miR) regulation of lipid metabolism via the MTP pathway, leading to reductions in apoB secretion and blood lipid levels. MiR regulation of the MTP pathway is shown herein to reduce hyperlipidemia and atherosclerosis in vivo. Therefore, inhibition of MTP expression and activity by miR regulation is identified as a new therapeutic target for treatment of cardiovascular disease and conditions or diseases associated with cardiovascular disease such as hyperlipidemia, atherosclerosis, and metabolic syndrome. Treatment of cardiovascular disease and associated conditions or diseases with the novel MTP inhibitors of the invention, such as miR-30c homologs or miR-30c agonists, reduces MTP-associated lipid production without side effects that occur with other methods of MTP inhibition.Type: GrantFiled: January 9, 2013Date of Patent: January 31, 2017Assignee: The Research Foundation for The State University of New YorkInventors: Mahmood Hussain, James Soh
-
Patent number: 9554995Abstract: The invention relates to nanoemulsions useful for analytical techniques and delivery of cargoes such as pharmaceutically active agents. In particular, the invention relates to nanoemulsions comprising an oil phase dispersed in an aqueous phase and at least two peptide surfactants adsorbed at the liquid-liquid interface, one peptide surfactant comprising a short peptide sequence having ?-helical propensity and at least one second polypeptide surfactant comprising at least two peptide sequences having ?-helical propensity linked by a linking sequence of 3 to 11 amino acid residues. Optionally the at least one second polypeptide surfactant comprises at least one pharmacokinetic modifying agent and/or a targeting agent. Furthermore, the nanoemulsion may further comprise a cargo such as a pharmaceutically active agent.Type: GrantFiled: June 13, 2013Date of Patent: January 31, 2017Assignee: The University of QueenslandInventors: Anton Peter Jacob Middelberg, Bijun Zeng
-
Patent number: 9557250Abstract: Embodiments of the present disclosure provide for particle-imprinted polymer films, methods of making particle-imprinted polymer films, methods for separating particles, devices or systems for separating particles, and the like.Type: GrantFiled: March 7, 2013Date of Patent: January 31, 2017Assignee: The Board of Trustees of the Leland Stanford Junior UniversityInventors: Romana Schirhagl, Richard N. Zare, Kangning Ren, Niaz Banaei
-
Patent number: 9554755Abstract: Methods, systems, and computer readable media for predicting early onset glaucoma via structural parameters obtained via time and spectral-domain optical coherence tomography (SD-OCT) are disclosed. SD-OCT technology measures the thicknesses of the layers of the retina that contain the cells that die in glaucoma before there is any functional loss. A multivariable predictive model may be used for the diagnosis of early glaucoma using a combination of optic nerve head (ONH), peripapillary retinal nerve fiber layer (RNFL), and macular ganglion cell-inner plexiform layer (GCIPL) parameters measured via SD-OCT. The model generates a glaucoma probability score for individual patient, which is valuable information in assisting clinicians in glaucoma diagnosis and treatment.Type: GrantFiled: October 13, 2015Date of Patent: January 31, 2017Assignee: The University of North Carolina at Chapel HillInventors: Jean-Claude Kasongo Mwanza, Donald Lyle Budenz, Joshua Lindsey Warren
-
Patent number: 9555405Abstract: Nanocatalysts and methods of using the same to obtain aromatic hydrocarbon compounds from a source of carbon atoms and a source of hydrogen atoms in a single reaction step is provided. The catalyst comprises an Fe/Fe3O4 nanocatalyst that may be supported on a non-reactive support material such as a zeolite or alumina CO2 and H2 are preferred sources of carbon and hydrogen atoms for the reaction. The aromatic hydrocarbon compounds produced are suitable for direct usage as fuel without need for further refining.Type: GrantFiled: January 23, 2015Date of Patent: January 31, 2017Assignee: Kansas State University Research FoundationInventors: Hongwang Wang, Stefan H. Bossmann, Donghai Wang, Deryl L. Troyer, Tej Shrestha
-
Patent number: 9555472Abstract: An arc melting and tilt casting apparatus having a casing provided with a vacuum chamber for housing a hearth having a melting trough and pouring means, arc-melting electrode means passing through the casing in the chamber, a mold having a melt receiving orifice, vacuum generating means, sealing means for maintaining the vacuum in the chamber and tilting means for tilting the apparatus to cause the melt to flow from the melting trough via the pouring means in the mold through the mold orifice. The hearth and mold are connected together and moveable as a single unit in the vacuum chamber and out from the chamber.Type: GrantFiled: May 11, 2012Date of Patent: January 31, 2017Assignee: Aalto University FoundationInventors: Erno Soinila, Tuomas Pihlajamaki, Sven Bossuyt, Hannu Hanninen
-
Patent number: 9556018Abstract: A three-dimensional nano-structure array includes a substrate and a number of three-dimensional nano-structures. Each three-dimensional nano-structure has a first peak and a second peak aligned side by side. A first groove is defined between the first peak and the second peak. A second groove is defined between the two adjacent three-dimensional nano-structures. A depth of the first groove is lower than that of the second groove.Type: GrantFiled: December 29, 2011Date of Patent: January 31, 2017Assignees: Tsinghua University, HON HAI PRECISION INDUSTRY CO., LTD.Inventors: Zhen-Dong Zhu, Qun-Qing Li, Li-Hui Zhang, Mo Chen, Yuan-Hao Jin, Shou-Shan Fan
-
Patent number: 9556281Abstract: Embodiments concern methods and compositions for treating or preventing a bacterial infection, particularly infection by a Staphylococcus bacterium. Aspects include methods and compositions for providing a passive immune response against the bacteria. In certain embodiments, the methods and compositions involve an antibody that binds Staphylococcal protein A (SpA).Type: GrantFiled: August 15, 2012Date of Patent: January 31, 2017Assignee: The University of ChicagoInventors: Olaf Schneewind, Dominique M. Missiakas, Hwan Keun Kim, Carla Emolo, Andrea DeDent
-
Patent number: 9555072Abstract: The invention provides viral vectors (e.g., herpes viral vectors) and methods of using these vectors to treat disease.Type: GrantFiled: October 27, 2014Date of Patent: January 31, 2017Assignees: The General Hospital Corporation, Georgetown University, Catherex, Inc.Inventors: Paul Johnson, Robert L. Martuza, Samuel D. Rabkin, Tomoki Todo
-
Patent number: 9557262Abstract: A method comprises: generating a first and a second correlated photon beam with wavelengths ?1 and ?2, respectively, wherein preferably ?1??2; separating the first photon beam and the second photon beam; illuminating an object with the first photon beam; generating a third and a fourth correlated photon beam with wavelength ?1 and wavelength ?2, respectively; overlapping the first photon beam with the third photon beam such that photons of wavelength ?1 in either photon beam are indistinguishable; overlapping the second photon beam with the fourth photon beam such that photons of wavelength ?2 in either photon beam are indistinguishable; and using the overlapped photons of wavelength ?2 for imaging and/or spectroscopy of the object such that the photons that illuminate the object are not detected.Type: GrantFiled: December 15, 2014Date of Patent: January 31, 2017Assignees: University of Vienna, The Austrian Academy of SciencesInventors: Anton Zeilinger, Sven Ramelow, Radek Lapkiewicz, Victoria Borish, Gabriela Barreto Lemos
-
Patent number: 9558018Abstract: Methods and apparatus for simulating a distributed business process are disclosed. The methods and apparatus simulate an interdependent business process, such as a financial transaction system, in a secure distributed manner. Each business entity that is part of the interdependent business process models itself on a local client device at any chosen level of detail. A simulation server connects the separate client based simulations into one large simulation. Details of each local simulation may be hidden from other simulation participants. However, interruptions in business flow caused by simulated disruptions introduced at the simulation server and/or a client device are propagated to all of the effected simulation participants via the simulation server. In addition, if a client based model is not available, the server supplies a software agent to replace the inputs and outputs normally associated with that portion of the overall simulation.Type: GrantFiled: April 12, 2016Date of Patent: January 31, 2017Assignee: Norwich University Applied Research InstitutesInventors: Andrew W. Cutts, Robert Schmidt